TrialAmerican journal of clinical dermatology2020

Botulinum Toxin Type B for Hidradenitis Suppurativa: A Randomised, Double-Blind, Placebo-Controlled Pilot Study.

Øystein Grimstad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.